Your account is not claimed yet. You can sign up with ORCID to claim your account.

Paul A Reynolds

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

High Throughput

Combination Therapy

Top Venues

Science advances

Scientific reports

University of St Andrews

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of St Andrews

United Kingdom

Lecturer :: Medicine

Education History

University of Bristol Oct 1o 1993 - Oct 1o 1996

United Kingdom

PHD :: Pathology

Publications

Mustafa Elshani, In Hwa Um, Steve Leung, Paul A Reynolds, Alex Chapman, Mary Kudsy, David J Harrison
Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage. Cells 12 (17) (2023)
Awa Sarr, Jennifer Bré, In Hwa Um, Tsz Huen Chan, Peter Mullen, David J Harrison, Paul A Reynolds
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031. Scientific reports 9 (1) (2019)
Kathryn E Haley, Nils M Kronenberg, Philipp Liehm, Mustafa Elshani, Cameron Bell, David J Harrison, Malte C Gather, Paul A Reynolds
Podocyte injury elicits loss and recovery of cellular forces. Science advances 4 (6) (2018)